DR LAL PATHLABS
Back to Income Statement
|
DR LAL PATHLABS Last 5 Year Total Expenditure History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Expenditure | ₹1,617 Cr | ₹1,527 Cr | ₹1,527 Cr | ₹1,145 Cr | ₹987 Cr |
What is the latest Total Expenditure of DR LAL PATHLABS ?
Year | Total Expenditure |
---|---|
Mar2024 | ₹1,617 Cr |
Mar2023 | ₹1,527 Cr |
Mar2022 | ₹1,527 Cr |
Mar2021 | ₹1,145 Cr |
Mar2020 | ₹987 Cr |
How is Total Expenditure of DR LAL PATHLABS Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2024 | ₹1,617 Cr | 5.92 | |
Mar2023 | ₹1,527 Cr | 0.02 | |
Mar2022 | ₹1,527 Cr | 33.34 | |
Mar2021 | ₹1,145 Cr | 16.03 | |
Mar2020 | ₹987 Cr | - |
Compare Total Expenditure of peers of DR LAL PATHLABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR LAL PATHLABS | ₹25,354.2 Cr | 0.2% | -3.3% | 15% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹100,347.0 Cr | 3.5% | 0.6% | 27.9% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹97,859.7 Cr | 1.7% | 7.3% | 59.9% | Stock Analytics | |
FORTIS HEALTHCARE | ₹48,721.2 Cr | -5.2% | 10.6% | 81.8% | Stock Analytics | |
GLOBAL HEALTH | ₹28,920.2 Cr | 0.4% | 1.5% | 23.1% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹25,800.6 Cr | 0.3% | 2.1% | 1.4% | Stock Analytics |
DR LAL PATHLABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR LAL PATHLABS | 0.2% |
-3.3% |
15% |
SENSEX | 3.4% |
0.2% |
21.7% |
You may also like the below Video Courses